Assay methods and materials
AssigneeSelective Antibodies Limited
InventorColin Self
Life of this patent
Estimating the term…
Loading patent…
AssigneeSelective Antibodies Limited
InventorColin Self
Estimating the term…
The invention relates to assays in which complexes between an analyte and a binding agent specific for the analyte are detected by a reporter molecule, which is capable of binding to the binding agent when the binding agent is complexed with analyte but not when the binding agent is complexed with an analyte analogue. The invention provides a method of modifying such a binding agent in order to create a tailored site where the reporter molecule may bind to the binding agent. This provides control over the location and nature of the reporter binding site. Antibodies, including bispecific antibodies, are preferred binding agents. The invention also provides novel methods for labelling antibodies close to their antigen binding site using bi- and tri-functional reagents. Modified binding agents produced by the methods described are also provided.
A method of determining an analyte in a sample, comprising the steps of
A method according to any one of the preceding claims wherein said binding agent is an antibody or enzyme.
A method according to any one of the preceding claims wherein said analyte analogue is an antibody directed against said analyte binding site.
A method according to anyone of the preceding claims wherein the analyte is a drug of abuse or a metabolite thereof, such as cocaine or benzoyl ecgonine.
A method of labelling a binding agent having an analyte binding site for an analyte, comprising the steps of:
A method of preparing a kit for use in determining an analyte in a sample, comprising
A method of determining an analyte in a sample, comprising contacting the sample with
A kit for determining an analyte in a sample, comprising
A modified binding agent, wherein the binding agent has an analyte binding site capable of binding either said analyte or an analyte analogue, wherein said modification comprises the creation of a reporter site adapted to interact in a detectable manner with a reporter molecule when the modified binding agent is bound to analyte, but not when the modified binding agent is bound to analyte analogue.
Dependencies are inferred from the claim text.